智通财经APP获悉，微创机器人-B(02252)涨超5%，截至发稿，涨5.59%，报24.55港元，成交额4.01亿港元。
消息面上，近年来，全球手术机器人市场迎来爆发式增长。据弗若斯特沙利文预测，到2030年，中国手术机器人市场规模将突破700亿元，年复合增长率超30%。据微创机器人此前披露，公司24年旗下腔镜、骨科、血管介入核心产品的综合订单量已累计超过100台。期间，图迈腔镜手术机器人全球订单达39台，商业化装机突破30台，全球累计商业化订单近60台。
西南证券研报指出，公司“五分之四”机器人版图已成，2025-2026年将是重要扭亏节点；此外，国内配置证政策放松带来市场扩容，2023年6月新版医用设备配置证中腹腔内窥镜手术机器人规划数新增215%，公司订单量连续2年实现翻倍以上增长；海外市场快速突破，商业化首年即获批20+海外订单，5G远程手术方案助力学术推广和装机入院。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.